 High-potency, second-generation antipsychotics, sometimes combined with benzodiazepines, are effective in controlling psychomotor agitation; however, unwanted adverse effects, which are sometimes severe and even lifethreatening have been concomitantly described with their use.  In an emergency setting an induction of sedation with high potency antipsychotics may impair detailed evaluation and monitoring of the medical condition underlying psychomotor agitation.  The current goal of pharmacological intervention is the induction of tranquilization (defined as a significant reduction in symptoms of agitation and aggression) without the induction of deep or prolonged sedation, while keeping the patient calm yet completely or partially responsive with the lowest possible frequency of adverse effects.
Contrast analysis pointed to a treatment effect of levels of tranquilization with the combination HLP+PMZ (P=0.035) and ZIP (P=0.043) that was lower than the treatment effects obtained by the combination HLP+MID, which did not differ from OLZ (P=0.604) . o Statistically significant effects of tranquilization were observed over time with the measurements obtained by the PANSS-EC (P<0.001), without significant differences between treatment groups (P=0.216). o Statistically significant reduction in heart rate during the first 90 minutes (P=0.022) independent of treatment.
Non-significant reduction in systolic blood pressure over time (P=0.170). Significant reduction in diastolic blood pressure during this period (P=0.008), regardless of treatment group (P=0.153).  Secondary outcome measure:
o Occurrence of at least 1 extrapyramidal symptom within 24 hours after drug intervention was observed in 20 patients treated with HLP+PMZ, 14 patients treated with OLP, 12 patients treated with ZIP, and 11 patients treated with HLP+MID. o Logical regression analysis showed that patients treated with HLP+PMZ had a significantly increased risk of developing extrapyramidal symptoms than those treated with HLP+HLP. Statistical significance remained even after other variables (prior psychotropic medication use, need for an additional dose, and ultimate psychiatric diagnosis) were included in the model.
STRENGTHS
 Parallel study design  Both patients and investigators were blinded to the treatment throughout the study; unblinding was not likely  Evaluators received standardized and systemic training on using the rating scales used in the study before the process of data collection commenced  Due to the nature of the study, dropout was not an issue
LIMITATIONS
 There was variation in the clinical features between some the treatment groups at baseline  Study was conducted at only one center  Low-dosing of the study medications should have been more standardized, specifically in regards to the dose of midazolam  67% of patients had been medicated before admission to the emergency department
CONCLUSIONS
 Low doses of antipsychotics can be effective for the management of agitated patients without excessive sedation.  Low-cost medications, such as haloperidol + short half-life benzodiazepine, might be as effective as new generation antipsychotics, without significant differences in extrapyramidal effects.  In practice, the combination of haloperidol + promethazine should only be considered a second line option because of the risk of extrapyramidal effects.
o Additional multicenter studies with larger samples are needed to confirm the findings of this investigation. 
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